Immunosignature Screening for Multiple Cancer Subtypes Based on Expression Rule

MLA

Lei Chen, et al. “Immunosignature Screening for Multiple Cancer Subtypes Based on Expression Rule.” Frontiers in Bioengineering and Biotechnology, vol. 7, Nov. 2019. EBSCOhost, https://doi.org/10.3389/fbioe.2019.00370.

APA

Lei Chen, XiaoYong Pan, Tao Zeng, Yu-Hang Zhang, YunHua Zhang, Tao Huang, & Yu-Dong Cai. (2019). Immunosignature Screening for Multiple Cancer Subtypes Based on Expression Rule. Frontiers in Bioengineering and Biotechnology, 7. https://doi.org/10.3389/fbioe.2019.00370

Chicago

Lei Chen, XiaoYong Pan, Tao Zeng, Yu-Hang Zhang, YunHua Zhang, Tao Huang, and Yu-Dong Cai. 2019. “Immunosignature Screening for Multiple Cancer Subtypes Based on Expression Rule.” Frontiers in Bioengineering and Biotechnology 7 (November). doi:10.3389/fbioe.2019.00370.